Blood, Sweat and Smears - A Machaon Diagnostics Podcast

HLH, CXCL9 and Clinical Decision-Making with Dr. Joe Rocco

In this episode, our Medical Director, Dr. Brad Lewis, talks with Dr. Joe Rocco, a NIAID Assistant Clinical Investigator who specializes in Hemophagocytic Lymphohistiocytosis (HLH). Dr. Lewis and Dr. Rocco discuss HLH and the evolving approach to recognizing and managing this life-threatening hyperinflammatory syndrome. The conversation focuses on early clinical recognition, the role of CXCL9 as a dynamic marker of interferon-gamma activity, and how recent multicenter data support using CXCL9 to stratify risk, guide treatment urgency, and improve outcomes in critically ill patients. Click for more information on our HLH Genetic Panel or visit us at MachaonDiagnostics.com.

Clinical Research Focus - Candy Bermingham, Arcus Biosciences

In this episode, we focus on the research side of Machaon Diagnostics. Dive into the future of medicine with this podcast, which explores how exciting new therapeutics are developed, touching on oncology and the revolutionary CAR-T modality. Violet Votin, PhD, Associate Director of Scientific Affairs at Machaon, chats with Candy Bermingham, PhD, Vice President and Head of Clinical Science at Arcus Biosciences. Discover how assay selection criteria and fast, reliable laboratory testing are shaping the next generation of therapeutic breakthroughs.Interested in CAR-T and other cell therapies? Check out our new CRS panel: https://www.machaondiagnostics.com/test/cytokine-release-syndrome-12-test-panel/.

5 Questions with Dr. James Malone

5 Questions is a new series of Blood, Sweat and Smears, hosted by our Senior Director, Bjorn Stromsness, who asks 5 questions to physicians in and around the disease areas we work in. In this episode, we are joined by Clinical Associate Professor of Hematology at Stanford Medicine, Dr. James Malone, Colonel and Command Surgeon of the U.S. Army Reserves. 

A Year of mHam 2.0 - Three Observations with host Dr. Brad Lewis

A retrospective look at the Modified Ham (mHam 2.0) Complement-Dependent Cell Killing Assay, one year after its release.Don't forget, this test has a STAT TAT of < 24 hours (M-F).Visit ➡️ https://mham.machaondiagnostics.com/ to learn more. 

5 Questions with Dr. Ebens

5 Questions is a new series of Blood, Sweat and Smears, hosted by our Senior Director, Bjorn Stromsness, who asks 5 questions to physicians in and around the disease areas we work in. In this episode, we are joined by Dr. Christen Ebens, MD, MPH, Associate Professor in the Division of Pediatric Blood and Marrow Transplantation & Cellular Therapy Program at the University of Minnesota.